UK Statutory Instrument 2024 United Kingdom

Medical Devices (Post-market Surveillance Requirements) (Amendment) (Great Britain) Regulations 2024

At a glance

Enforced by

MHRA

What's here

3 practical guides · 4 journeys

Step-by-step journeys using this legislation

Walkthroughs that take you from a real business situation to compliance.

Relevant guidance

Practical guides for businesses affected by this Act, ordered by how closely they engage with it.

Mentioned in related content

1 guides

What this Act requires

Sections that create concrete duties on businesses or carry penalties. Procedural and definitional sections are folded into the “Browse other sections” expander at the bottom of each group. Click any section title to read the source text on legislation.gov.uk.

Browse 6 other sections — procedural / definitional / commencement
s.001

Citation, commencement, extent and application

s.002

Amendments to the Medical Devices Regulations 2002

s.003

Amendment to regulation 2 (interpretation)

s.004

New Part 4A (post-market surveillance requirements)

s.005

Amendment to Schedule 2A

s.006

Saving provision

Official guidance

Authoritative sources published by regulators or government explaining this legislation.

Enforcement and responsible bodies

The regulators that administer or enforce this legislation.

Medicines and Healthcare products Regulatory Agency

Regulates medicines, medical devices, and blood components. Ensures safety, quality, and efficacy. Issues marketing authorisations.

Explore more

Browse legislation

Find other UK business legislation with related guidance.

Regulators

Learn more about the bodies that enforce this legislation.